Geriatrician; Head of Aged Care and Memory Clinic, Austin Health
Prof Michael Woodward AM is a Geriatrician with a passion for health promotion in older people, including vaccine-preventable diseases. He is Director of Aged Care Research at Austin Health and has conducted several trials of vaccines. He is a member of the Scientific Advisory Committee of the Immunization Coalition and has written the Position Paper on Immunization of older people for the Australian and New Zealand Society of Geriatric Medicine. In 2016 he received Membership of the Order of Australia for his work in geriatric medicine and his communication to professionals.
In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).
In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1
In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...
In this Product Explainer, Geriatrician A/Prof Michael Woodward AM provides an update on the recombinant (ie non-live) herpes zoster vaccine and inclusion in the National Immunisation Program.
In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).
This article discusses how GPs can improve the vaccination coverage among older Australians which is currently poor despite the ready availability, safety and effectiveness of these vaccines. Written by A/Prof Michael Woodward AM, MB, BS, MD, FRACP, and A/Prof John Litt MB, BS, DRACOG, MSc(Epid), FRACP, FAFPHM, PhD
This article discusses how GPs can improve the vaccination coverage among older Australians which is currently poor despite the ready availability, safety and effectiveness of these vaccines. Written by A/Prof Michael Woodward AM, MB, BS, MD, FRACP, and A/Prof John Litt MB, BS, DRACOG, MSc(Epid), FRACP, FAFPHM, PhD
In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains the evidence for Souvenaid, a medical food, to support memory and cognitive function in patients in the early stages of Alzheimer's disease (5 mins).
In this Product Explainer, Geriatrician A/Prof Michael Woodward AM provides an update on the recombinant (ie non-live) herpes zoster vaccine and inclusion in the National Immunisation Program.
In this episode, understand whether RSV is more serious than influenza. It's impacts on morbidity and mortality in the elderly are underestimated and effective prevention strategies for the Australian community are imminent...
In this Product Explainer Geriatrician A/Prof Michael Woodward AM explains an adjuvanted vaccine indicated for the active immunisation of individuals 60 years and older for the prevention of lower respiratory tract disease caused by respiratory syncytial virus (RSV).1
In this Product Explainer, Geriatrician A/Prof Michael Woodward AM explains the role of a medical food in the management of patients with mild cognitive impairment (MCI).
Save 50% on all seminars. Hurry, sale ends Dec 31!
You're invited to attend the Women's & Children's Health Update 2026, Australia's most popular seminar for GPs and healthcare professionals. Secure your seat by midnight Dec 31 and save!